Skip Navigation

European Heart Journal 1999 20(3):174-195; doi:10.1053/euhj.1998.1220
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (77)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Priori, S.G.
Right arrow Articles by Wilde, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priori, S.G.
Right arrow Articles by Wilde, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Communications

Genetic and molecular basis of cardiac arrhythmias

Impact on clinical management

S.G. Priorif1, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, P.J. Schwartz, J.A. Towbin and A. Wilde

Received July 14, 1998; accepted July 15, 1998

Key Words: Sudden cardiac death • genetics • arrhythmia • molecular diagnosis • basic electrophysiology

f1 Correspondence: Silvia G. Priori, MD, PhD, Molecular Cardiology and Electrophysiology Laboratory, Fondazione ‘S. Maugeri’ IRCSS, Via Ferrata, 8, 27100 Pavia, Italy.

Zipes, DPJalife, J

References

  1. Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399–411[CrossRef][Web of Science][Medline]
  2. Schwartz PJ, Locati EH, Napolitano C, Priori SG. The long QT syndrome. Cardiac electrophysiology. From cell to bedside. Philadelphia: WB Saunders Co; 1995. p. 788–811
  3. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell’età pediatrica. Clin Pediatr. 1963;45:658–683
  4. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54:59–68[CrossRef][Web of Science][Medline]
  5. Wang Q, Curran ME, Splawski I. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23[CrossRef][Web of Science][Medline]
  6. Jiang C, Atkinson D, Towbin JA. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994;8:141–147[CrossRef][Web of Science][Medline]
  7. Towbin JA, Li H, Taggart RT, Lehmann MH. Evidence of genetic heterogeneity in Romano–Ward long QT syndrome. Analysis of 23 families. Circulation. 1994;90:2635–2644[Abstract/Free Full Text]
  8. Schott JJ, Peltier S, Foley P. Mapping of a new gene for the LQTS syndrome. Am J Hum Genet. 1995;57:1114–1122[Web of Science][Medline]
  9. Wang Q, Shen J, Splawski I. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–811[CrossRef][Web of Science][Medline]
  10. Bennett PB, Yazawa K, Makita N, George AJ. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683–685[CrossRef][Medline]
  11. Dumaine R, Wang Q, Keating MT. Multiple mechanisms of Na+. Circ Res. 1996;78:916–924[Abstract/Free Full Text]
  12. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803[CrossRef][Web of Science][Medline]
  13. Sanguinetti MC, Curran ME, Zou A. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996;384:80–83[CrossRef][Medline]
  14. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and 1sK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 1996;384:78–80[CrossRef][Web of Science][Medline]
  15. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long-QT syndrome and suppress IKs. Nature Genet. 1997;17:338–340[Web of Science][Medline]
  16. Schulze-Bah E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nature Genet. 1997;17:267–268[CrossRef][Web of Science][Medline]
  17. De Jager T, Corbett CH, Badenhorst JC, Brink PA, Corfield VA. Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet. 1996;33:567–573[Abstract/Free Full Text]
  18. Napolitano C, Priori SG, Schwartz PJ. Identification of a mutational hot spot in HERG-related long QT-syndrome (LQT2). Phenotypic implications (Abstr). Circulation. 1997;96:I–212
  19. Neyroud N, Tesson F, Denjoy I. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15:186–189[CrossRef][Web of Science][Medline]
  20. Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med. 1997;336:1562–1567[Free Full Text]
  21. Priori SG, Schwartz PJ, Napolitano C. A recessive variant of the Romano–Ward long QT syndrome? Circulation. 1998;97:2420–2425[Abstract/Free Full Text]
  22. Vincent GM, Timothy KM, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for long QT syndrome. N Engl J Med. 1992;327:846–852[Abstract]
  23. Donger C, Denjoy I, Berthet M. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 1997;96:2778–2781[Abstract/Free Full Text]
  24. Priori SG, Napolitano C, Casari G, Bloise R, Schwartz PJ. Variable penetrance in the long QT syndrome. Impact on diagnosis (Abstr). PACE. 1998;38:
  25. Neyroud N, Denjoy I, Donger C. Heterozygous mutation in the pore of potassium channel gene KvLQT1 causes an apparent normal phenotype in long QT syndrome. Eur J Hum Genet. 1998;6:129–133[CrossRef][Web of Science][Medline]
  26. Sanguinetii MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+. Proc Natl Acad Sci USA. 1996;93:2208–2212[Abstract/Free Full Text]
  27. Chouabe C, Neyroud N, Guiceney P, Lazdunski M, Romey G, Barhanin J. Properties of KvLQT1 K channel mutations in Romano–Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 1997;17:5472–5479[CrossRef]
  28. Schwartz PJ, Moss AL, Priori SG. Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome (Abstr). Circulation. 1997;96:I–212
  29. Schwartz PJ, Priori SG, Locati EH. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+. Circulation. 1995;92:3381–3386[Abstract/Free Full Text]
  30. Compton SJ. QT interval shortening by lidocaine in chromosome 7-linked long QT syndrome (LQTS) (Abstr). PACE. 1997;20:1060
  31. Compton SJ, Lux RL, Ramsey MR. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation. 1996;94:1018–1022[Abstract/Free Full Text]
  32. Schwartz PJ, Moss AJ. QT interval prolongation. What does it mean? J Cardiovasc Med. 1982;7:1317–1330
  33. Priori SG, Diehl L, Schwartz PJ. Torsade de pointes. Podrid PJ, Kowey PR. Cardiac arrhythmia, mechanisms, diagnosis and management. Baltimore: Williams & Wilkins; 1995. p. 951–963
  34. Schulze-Bahr E, Haverkamp W, Hördt M. A genetic basis for quinidine-induced (acquired) long QT syndrome (Abstr). Eur Heart J. 1997;18:29
  35. Napolitano C, Priori SG, Schwartz PJ. Identification of a long QT sydrome molecular defect in drug-induced torsade de pointes (Abstr). Circulation. 1997;96:211
  36. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–785[Free Full Text]
  37. Geisterfer LA, Kass S, Tanigawa G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006[CrossRef][Web of Science][Medline]
  38. Poetter K, Jiang H, Hassanzadeh S. Mutation in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13:63–69[CrossRef][Web of Science][Medline]
  39. Thierfelder L, Watkins H, MacRae C. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701–712[CrossRef][Web of Science][Medline]
  40. Bonne G, Carrier L, Bercovici J. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438–440[CrossRef][Web of Science][Medline]
  41. Watkins H, Conner D, Thierfelder L. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434–437[CrossRef][Web of Science][Medline]
  42. Kimura A, Harada H, Park JE. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 1997;16:379–382[CrossRef][Web of Science][Medline]
  43. MacRae CA, Ghaisas N, Kass S. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7p3. Clin Invest. 1995;96:1216–1220
  44. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 1995;91:532–540[Free Full Text]
  45. Vikstrom KL, Leinwand LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol. 1996;8:97–105[CrossRef][Web of Science][Medline]
  46. Carrier L, Bonne G, Bahrend E. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 1997;80:427–434[Web of Science][Medline]
  47. Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND. Skeletal muscle expression and abnormal function of ß-myosin in hypertrophic cardiomyopathy. J Clin Invest. 1993;91:2861–2865[Web of Science][Medline]
  48. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing ß-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 1995;95:1409–1414[Web of Science][Medline]
  49. Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem. 1994;269:1603–1605[Abstract/Free Full Text]
  50. Watkins H, Rosenzweig A, Hwang DS. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108–1114[Abstract]
  51. Dausse E, Komajda M, Fetler L. Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the ß-myosin heavy chain gene. J Clin Invest. 1993;92:2807–2813[Web of Science][Medline]
  52. Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the ß-myosin heavy chain gene. A 908Leu-Val mutation and a 403Arg-Gln mutation. Circulation. 1992;86:345–352[Abstract/Free Full Text]
  53. Charron, P, Dubourg, O, Desnos, M
  54. Watkins H, McKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058–1064[Abstract/Free Full Text]
  55. Forissier JF, Carrier L, Farza H. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation. 1996;94:3069–3073[Abstract/Free Full Text]
  56. Moolman JC, Corfield VA, Posen B. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549–555[Abstract]
  57. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983–991[Abstract/Free Full Text]
  58. Coonar AS, Protonotarios N, Tsatsopoulou A. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to chromosome 17q21. Circulation. 1998;97:2049–2058[Abstract/Free Full Text]
  59. Rampazzo A, Nava A, Danieli GA. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23–q24. Hum Mol Genet. 1994;3:959–962[Abstract/Free Full Text]
  60. Severini GM, Krajinovic M, Pinamonti B. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics. 1996;31:193–200[CrossRef][Web of Science][Medline]
  61. Rampazzo A, Nava A, Erne P. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42–q43. Hum Mol Genet. 1995;4:2151–2154[Abstract/Free Full Text]
  62. Rampazzo A, Nava A, Miorin M. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 2 long arm. Genomics. 1997;45:259–263[CrossRef][Web of Science][Medline]
  63. Michels VV, Moll PP, Miller FA. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77–82[Abstract]
  64. Stamato NJ, O’Connell JB, Murdock DK, Moran JF, Loeb HS, Scanlon PJ. The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation. Am Heart J. 1986;112:505–508[CrossRef][Web of Science][Medline]
  65. Stevenson WG, Stevenson LW, Weiss J, Tillisch JH. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J. 1988;116:1447–1454[CrossRef][Web of Science][Medline]
  66. Schultz KR, Garjarski RJ, Pignatelli R. Genetic heterogenity in familial dilated cardiomyopathy. Biochem Mol Med. 1995;56:87–93[CrossRef][Web of Science][Medline]
  67. Towbin JA, Hejtmancik JF, Brink P. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854–1865[Abstract/Free Full Text]
  68. Ortiz LR, Li H, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutuation as a cause of X-linked dilated cardiomyopathy. Circulation. 1997;95:2434–2440[Abstract/Free Full Text]
  69. Bione S, D’Adamo P, Maestrini E, Gedeom AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4·5. is responsible for Barth syndrome. Nat Genet. 1996;12:385–389[CrossRef][Web of Science][Medline]
  70. Muntoni F, Cau M, Ganau A. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921–925[Free Full Text]
  71. Muntoni F, Wilson L, Marrosu G. A mutuation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 1995;96:693–699[Web of Science][Medline]
  72. Milasin J, Muntoni F, Severini GM. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet. 1996;5:73–79[Abstract/Free Full Text]
  73. Durand JB, Bachinski LL, Bieling LC. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 1995;92:3387–3389[Abstract/Free Full Text]
  74. Siu, BL, A novel locus for familial dilated cardiomyopathy on chromosome 2p31, Proceedings of the second world congress of pediatric cardiology and cardiac surgery, 1997
  75. Krajinovic M, Pinamonti B, Sinagra G. Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet. 1995;57:846–852[Web of Science][Medline]
  76. Bowles KR, Gajarski R, Porter P. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21–23. J Clin Invest. 1996;98:1355–1360[Web of Science][Medline]
  77. Kass S, MacRae C, Graber HL. A gene defect that causes conduction system disease and dilated cariomyopathy maps to chromosome 1p1–1q1. Nat Genet. 1994;7:546–551[CrossRef][Web of Science][Medline]
  78. Olson TM, Keating MT. Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22–p25. J Clin Invest. 1996;97:528–532[Web of Science][Medline]
  79. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy a heritable form of heart failure. Science. 1998;280:750–753[Abstract/Free Full Text]
  80. Consensus statement of the Joint Steering Committees of UCARE and of IVF-US, Bardy GH, Bigger JT Jr, Borggrefe M. Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation. Circulation. 1997;95:265–272[Abstract/Free Full Text]
  81. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–1396[Abstract]
  82. Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293–294[CrossRef][Medline]
  83. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–1968[Abstract/Free Full Text]
  84. van der Velden HMW, van Zijverden M, van Kempen MJA. Abnormal expression of the gap junction protein connexin 40 during chronic atrial fibrillation in the goat (Abstr). Circulation. 1996;94:I-593
  85. Yue L, Feng J, Gaspo R, Li GR, Nattel S. Ionic remodeling underlying tachycardia-induced atrial fibrillation in dogs (Abstr). Circulation. 1996;94:I-592
  86. Tieleman RG, De Langen C, Van Geldez IC. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation. 1997;95:1945–1953[Abstract/Free Full Text]
  87. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:833–842[Web of Science][Medline]
  88. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512–525[Abstract/Free Full Text]
  89. Burgada R, Tapscott T, Czernuszewicz GZ. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336:905–911[Abstract/Free Full Text]
  90. Brink PA, Ferreira A, Moolman JC, Weymar HW, Van der Merve PL, Corfield VA. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation. 1995;91:1633–1640[Abstract/Free Full Text]
  91. Brink AJ, Torrington M. Progressive familial heart block: two types. S Afr Med J. 1977;52:53–59[Web of Science][Medline]
  92. De Meeus A, Stephan E, Debrus S. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res. 1995;77:735–740[Abstract/Free Full Text]
  93. Priori SG. Is long QT syndrome entering the era of molecular diagnosis? Heart. 1997;77:5–6[Free Full Text]
  94. Priori SG, Napolitano C, Cantù F, Brown AM, Schwartz PJ. Differential response to Na+. Circ Res. 1996;78:1009–1015[Abstract/Free Full Text]
  95. Noda M, Shimizu S, Tanabe T. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature. 1984;312:121–127[Medline]
  96. Deal KK, England SK, Tamkun MM. Molecular physiology of cardiac potassium channels. Physiol Rev. 1996;76:49–67[Abstract/Free Full Text]
  97. Hosey MM, Chien AJ, Puri TS. Structure and regulation of L-Type calcium channels. A current assessment of the properties and roles of channel subunits. Trend Cardiovasc Med. 1996;6:265–273[CrossRef][Web of Science]
  98. Roden DM, George A Jr. Structure and function of cardiac sodium and potassium channels. Am J Physiol. 1997;273:H511–H525
  99. Isom LL, Dejongh KS, Catterall WA. Auxiliary subunits of voltage-gated ion channels. Neuron. 1994;12:1183–1194[CrossRef][Web of Science][Medline]
  100. Adelman JP. Proteins that interact with the pore-forming subunits of voltage- gated ion channels. Curr Opin Neurobiol. 1995;5:286–295[CrossRef][Web of Science][Medline]
  101. Scannevin RH, Trimmer JS. Cytoplasmic domains of voltage-sensitive K+. Biochem Biophys Res Commun. 1997;232:585–589[CrossRef][Web of Science][Medline]
  102. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr. Cell. 1995;81:299–307[CrossRef][Web of Science][Medline]
  103. McDonald TV, Yu Z, Ming Z. A minK-HERG complex regulates the cardiac potassium current IKr. Nature. 1997;388:289–292[CrossRef][Web of Science][Medline]
  104. Yang T, Kupershmidt S, Roden DM. Anti-minK antisense decreases the amplitude of the rapidly activating cardiac delayed rectifer K+. Circ Res. 1995;77:1246–1253[Abstract/Free Full Text]
  105. Dixon JE, Shi W, Wang HS. Role of the Kv4·3K+. Circ Res. 1996;79:659–668[Abstract/Free Full Text]
  106. Tyson J, Tranebjærg L, Bellman S. IsK and KvLQTl: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet. 1997;6:2179–2185[Abstract/Free Full Text]
  107. Vetter DE, Mann JR, Wangemann P. Inner ear defects induced by null mutation of the IsK gene. Neuron. 1996;17:1251–1264[CrossRef][Web of Science][Medline]
  108. Wang L, Feng ZP, Kondo CS, Sheldon RS, Duff HJ. Development changes in the delayed rectifier K+. Circ Res. 1996;79:79–85[Abstract/Free Full Text]
  109. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res. 1996;78:15–25[Abstract/Free Full Text]
  110. Lipka LJ, Siegelbaum SA, Robinson RB, Berman MF. An analogue of cAMP mimics developmental change in neonatal rat ventricular myocyte sodium current kinetics. Am J Physiol. 1996;270:H194–H199
  111. Zhang JF, Robinson RB, Siegelbaum SA. Sympathetic neurons mediate developmental change in cardiac sodium channel gating through long-term neurotransmitter action. Neuron. 1992;9:97–103[CrossRef][Web of Science][Medline]
  112. Yang T, Roden DM. Regulation of sodium current development in cultured atrial tumor myocytes (AT-1 cells). Am J Physiol. 1996;271:H541–H547
  113. Kupershmidt S, Yang T, Roden DM. Inhibition of ß-subunit expression prevents development of mature sodium current phenotype in cultured heart cells (Abstr). Circulation. 1996;94:I-287
  114. Malfatto G, Rosen TS, Steinberg SF. Sympathetic neural modulation of cardiac impulse initiation and repolarization in the newborn rat. Circ Res. 1990;66:427–437[Abstract/Free Full Text]
  115. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation. 1990;82:1095–1105[Free Full Text]
  116. Abrahamsson C, Palmer M, Ljung B. Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant. Cardiovasc Res. 1994;28:337–344[Abstract/Free Full Text]
  117. Delorme B, Dahl E, Jarry GT. Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev Dyn. 1995;204:358–371[Web of Science][Medline]
  118. Delorme B, Dahl E, Jarry GT. Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ Res. 1997;81:423–437[Abstract/Free Full Text]
  119. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993;73:276–285[Abstract/Free Full Text]
  120. Brahmajothi MV, Morales MJ, Liu S, Rasmusson RL, Campbell DL, Strauss HC. In situ hybridization reveals extensive diversity of K+. Circ Res. 1996;78:1083–1089[Abstract/Free Full Text]
  121. Kupershmidt S, Sutherland M, King D, Magnuson MA, Roden DM. Replacement by homologous recombination of the minK gene with LacZ reveals cell-specific minK expression (Abstr). Biophys J. 1997;72:A226
  122. Antzelevitch C, Sicouri S, Litovsky SH. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res. 1991;69:1427–1449[Free Full Text]
  123. Strauss HC, Bigger JJ, Hoffman BF. Electrophysiological and ß-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970;26:661–678[Abstract/Free Full Text]
  124. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Circ Res. 1985;56:857–867[Abstract/Free Full Text]
  125. Liu DW, Antzelevitch C. Characteristics of the delayed rectifer current (IKrKsKs. Circ Res. 1995;76:351–365[Abstract/Free Full Text]
  126. Dixon JE, McKinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ Res. 1994;75:252–260[Abstract/Free Full Text]
  127. Näbauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 1996;93:168–177[Abstract/Free Full Text]
  128. Po S, Roberds S, Snyders DJ, Tamkun MM, Bennett PB. Heteromultimeric assembly of human potassium channels. Molecular basis of a transient outward current? Circ Res. 1993;72:1326–1336[Abstract/Free Full Text]
  129. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays. 1996;18:719–730[CrossRef][Web of Science][Medline]
  130. Anumonwo JM, Wang Hz, Trabka JE. Gap junctional channels in adult mammalian sinus nodal cells. Immunolocalization and electrophysiology. Circ Res. 1992;71:229–239[Abstract/Free Full Text]
  131. Trabka JE, Coombs W, Lemanski LF, Delmar M, Jalife J. Immunohistochemical localization of gap junction protein channels in hamster sinoatrial node in correlation with electrophysiologic mapping of the pacemaker region. J Cardiovasc Electrophysiol. 1994;5:125–137[Web of Science][Medline]
  132. ten Velde I, de Jonge B, Verheijck EE, van KM, Analbers L, Gros D, Jongsma HJ. Spatial distribution of connexin43, the major cardiac gap junction protein, visualizes the cellular network for impulse propagation from sinoatrial node to atrium. Circ Res. 1995;76:802–811[Abstract/Free Full Text]
  133. Guerrero PA, Schuessler RB, Davis LM. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest. 1997;99:1991–1998[Web of Science][Medline]
  134. Kanter HL, Laing JG, Beau SL, Beyer EC, Saffitz JA. Distinct patterns of connexin expression in canine Purkinje fibers and ventricular muscle. Circ Res. 1993;72:1124–1131[Abstract/Free Full Text]
  135. Luo CH, Rudy Y. A dynamic model of the cardiac ventricular action potential I. Simulations of ionic currents and concentration changes. Circ Res. 1994;74:1071–1076[Abstract/Free Full Text]
  136. Fabiato A. Simulated calcium current can both cause calcium loading in and trigger calcium release from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol. 1985;85:291–320[Abstract/Free Full Text]
  137. Yue DT, Backx PH, Imredy JP. Calcium-sensitive inactivation in the gating of single calcium channels. Science. 1990;250:1735–1738[Abstract/Free Full Text]
  138. Sipido KR, Callewaert G, Carmeliet E. Inhibition and rapid recovery of Ca2+2+. Circ Res. 1995;76:102–109[Abstract/Free Full Text]
  139. Grantham CJ, Cannell MB. Ca2+. Circ Res. 1996;79:194–200[Abstract/Free Full Text]
  140. Zeng J, Rudy Y. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J. 1995;68:949–964[Web of Science][Medline]
  141. January CT, Riddle JM. Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+. Circ Res. 1989;64:977–990[Abstract/Free Full Text]
  142. Janse MJ, Steen AVD, Dam RV. Refractory period of the dog’s ventricular myocardium following sudden changes in frequency. Circ Res. 1969;24:251–262[Abstract/Free Full Text]
  143. Jack JJB, Noble D, Tsien RW. Electric Current Flow in Excitable Cells. Oxford: Clarendon Press; 1975.
  144. Buchanan JW, Saito T, Gettes LS. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ Res. 1985;56:696–703[Abstract/Free Full Text]
  145. Kléber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after inducation of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res. 1987;61:271–279[Abstract/Free Full Text]
  146. Riegger CB, Alperovich G, Kléber AG. Effect of oxygen withdrawal on active and passive electrical properties of arterially perfused rabbit ventricular muscle. Circ Res. 1989;64:532–541[Abstract/Free Full Text]
  147. Rudy Y, Quan W. A model study of the effects of the discrete cellular structure on electrical propagation in cardiac tissue. Circ Res. 1987;61:815–823[Abstract/Free Full Text]
  148. Peters NS. New insights into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischemic and hypertrophied human hearts. Clin Sci. 1996;90:447–452[Medline]
  149. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue: Roles of sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res. 1997;81:727–741[Abstract/Free Full Text]
  150. Joyner RW, Kumar R, Wilders R. Modulating L-type calcium current affects discontinuous cardiac action potential conduction. Biophys J. 1996;71:237–245[Web of Science][Medline]
  151. Weidmann S. Effect of current flow on cardiac muscle. J Physiol (London). 1951;115:227–236[Free Full Text]
  152. Le Grice IJ, Smaill BH, Chai LZ, Edgar SG, Gavin JB, Hunter PJ. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am J Physiol. 1995;38:H571–H582
  153. Spach MS, Josephson ME. Initiating reentry the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 1994;5:182–209[Web of Science][Medline]
  154. Cabo C, Pertsov AM, Baxter WT, Davidenko JM, Gray RA, Jalife J. Wave-front curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res. 1994;75:1014–1028[Abstract/Free Full Text]
  155. Fast VG, Kléber AG. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc Res. 1996;33:258–271
  156. Fast VG, Kléber AG. Cardiac tissue geometry as a determinant of unidirectional conduction block: assessment of microscopic excitation spread by optical mapping in patterned cell cultures and in a computer model. Cardiovasc Res. 1995;29:697–707[CrossRef][Web of Science][Medline]
  157. Rohr S, Salzberg BM. Characterization of impulse propagation at the microscopic level across geometrically defined expansions of excitable tissue: multiple site optical recording of transmembrane voltage (MSORTV) in patterned growth heart cell cultures. J Gen Physiol. 1994;104:287–309[Abstract/Free Full Text]
  158. Spach MS, Kootsey JM. Relating the sodium current and conductance to the shape of transmembrane and extra-cellular potentials by simulation: effects of propagation boundaries. IEEE Trans Biomed Eng. 1985;32:743–755[Web of Science][Medline]
  159. Iida M, Kodama I, Toyama J. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle. Cardiovasc Res. 1996;31:640–650[CrossRef][Web of Science][Medline]
  160. Rohr S, Kucera J. Involvement of the calcium inward current in cardiac impulse propagation: Induction of unidirection conduction block by nifedipine and reversal by K 8644. Biophys J. 1996;72:745–766
  161. Rohr S, Kucera JP, Fast VG, Kléber AG. Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science. 1997;275:841–844[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ESC Textbook of Cardiovascular MedicineHome page
D. Corrado, C. Basso, A. Pelliccia, and G. Thiene
CHAPTER 32 Sports and Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Pelliccia, D. P. Zipes, and B. J. Maron
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited: A Comparison of U.S. and European Criteria for Eligibility and Disqualification of Competitive Athletes With Cardiovascular Abnormalities
J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1990 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
W. Zheng, J. W. Verlander, I. J. Lynch, M. Cash, J. Shao, L. R. Stow, B. D. Cain, I. D. Weiner, S. M. Wall, and C. S. Wingo
Cellular distribution of the potassium channel KCNQ1 in normal mouse kidney
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F456 - F466.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. J. Heradien, A. Goosen, L. Crotti, G. Durrheim, V. Corfield, P. A. Brink, and P. J. Schwartz
Does Pregnancy Increase Cardiac Risk for LQT1 Patients With the KCNQ1-A341V Mutation?
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1410 - 1415.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. T. Locati
QT Interval Duration Remains a Major Risk Factor in Long QT Syndrome Patients
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1053 - 1055.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
M. Rocchetti, V. Freli, V. Perego, C. Altomare, G. Mostacciuolo, and A. Zaza
Rate dependency of {beta}-adrenergic modulation of repolarizing currents in the guinea-pig ventricle
J. Physiol., July 1, 2006; 574(1): 183 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
S. Geibel, N. Flores-Herr, T. Licher, and H. Vollert
Establishment of Cell-Free Electrophysiology for Ion Transporters: Application for Pharmacological Profiling
J Biomol Screen, April 1, 2006; 11(3): 262 - 268.
[Abstract] [PDF]

Home page
 JGPHome page
P. J. Stocker and E. S. Bennett
Differential Sialylation Modulates Voltage-gated Na+ Channel Gating throughout the Developing Myocardium
J. Gen. Physiol., February 27, 2006; 127(3): 253 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. J. Tester, M. L. Will, C. M. Haglund, and M. J. Ackerman
Effect of Clinical Phenotype on Yield of Long QT Syndrome Genetic Testing
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 764 - 768.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. R. Bezzina, W. Shimizu, P. Yang, T. T. Koopmann, M. W.T. Tanck, Y. Miyamoto, S. Kamakura, D. M. Roden, and A. A.M. Wilde
Common Sodium Channel Promoter Haplotype in Asian Subjects Underlies Variability in Cardiac Conduction
Circulation, January 24, 2006; 113(3): 338 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Pelliccia, R. Fagard, H. H. Bjornstad, A. Anastassakis, E. Arbustini, D. Assanelli, A. Biffi, M. Borjesson, F. Carre, D. Corrado, et al.
Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
Eur. Heart J., July 2, 2005; 26(14): 1422 - 1445.
[Full Text] [PDF]

Home page
 J. Physiol.Home page
D. Heitzmann, F. Grahammer, T. von Hahn, A. Schmitt-Graff, E. Romeo, R. Nitschke, U. Gerlach, H. J. Lang, F. Verrey, J. Barhanin, et al.
Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells
J. Physiol., December 1, 2004; 561(2): 547 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
D. J. Tester, D. B. Spoon, H. H. Valdivia, J. C. Makielski, and M. J. Ackerman
Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: A Molecular Autopsy of 49 Medical Examiner/Coroner's Cases
Mayo Clin. Proc., November 1, 2004; 79(11): 1380 - 1384.
[Abstract] [PDF]

Home page
 CirculationHome page
P. J. Schwartz
Stillbirths, Sudden Infant Deaths, and Long-QT Syndrome: Puzzle or Mosaic, the Pieces of the Jigsaw Are Being Fitted Together
Circulation, June 22, 2004; 109(24): 2930 - 2932.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. J Paavonen, H. Chapman, P. J Laitinen, H. Fodstad, K. Piippo, H. Swan, L. Toivonen, M. Viitasalo, K. Kontula, and M. Pasternack
Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG)
Cardiovasc Res, September 1, 2003; 59(3): 603 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Warth and J. Barhanin
The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R639 - R648.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Members of the Sicilian Gambit
New Approaches to Antiarrhythmic Therapy, Part I: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias
Circulation, December 4, 2001; 104(23): 2865 - 2873.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias
Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias
Cardiovasc Res, December 1, 2001; 52(3): 345 - 360.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
B Campanelli and J-M Chaudron
Long term follow up of long QT syndrome treated by overdrive pacing
Heart, November 1, 2001; 86(5): e14 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
W. Haverkamp, L. Eckardt, G. Monnig, E. Schulze-Bahr, H. Wedekind, P. Kirchhof, F. Haverkamp, and G. Breithardt
Clinical aspects of ventricular arrhythmias associated with QT prolongation
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K81 - K88.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]

Home page
 J. Physiol.Home page
M. Rocchetti, A. Besana, G. B Gurrola, L. D Possani, and A. Zaza
Rate dependency of delayed rectifier currents during the guinea-pig ventricular action potential
J. Physiol., August 1, 2001; 534(3): 721 - 732.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R.N.W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P.E. Vardas
Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology
Eur. Heart J., July 1, 2001; 22(13): 1074 - 1081.
[PDF]

Home page
 HeartHome page
K J Paavonen, H Swan, K Piippo, L Hokkanen, P Laitinen, M Viitasalo, L Toivonen, and K Kontula
Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome
Heart, July 1, 2001; 86(1): 39 - 44.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Lahat, M. Eldar, E. Levy-Nissenbaum, T. Bahan, E. Friedman, A. Khoury, A. Lorber, D. L. Kastner, B. Goldman, and E. Pras
Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia : Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21
Circulation, June 12, 2001; 103(23): 2822 - 2827.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
C. Basso, F. Calabrese, D. Corrado, and G. Thiene
Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings
Cardiovasc Res, May 1, 2001; 50(2): 290 - 300.
[Full Text] [PDF]

Home page
 EuropaceHome page
R. N. W. Hauer, E. Aliot, M. Block, A. Capucci, B. Luderitz, M. Santini, and P. E. Vardas
Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICD of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology
Europace, January 1, 2001; 3(3): 169 - 176.
[PDF]

Home page
 CirculationHome page
J. P. Mounsey and J. P. DiMarco
Dofetilide
Circulation, November 21, 2000; 102(21): 2665 - 2670.
[Full Text] [PDF]

Home page
 HeartHome page
D. M Roden
ELECTROPHYSIOLOGY: Antiarrhythmic drugs: from mechanisms to clinical practice
Heart, September 1, 2000; 84(3): 339 - 346.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A.J. Camm, M.J. Janse, D.M. Roden, M.R. Rosen, J. Cinca, and S.M. Cobbe
Congenital and acquired long QT syndrome
Eur. Heart J., August 1, 2000; 21(15): 1232 - 1237.
[PDF]

Home page
 HeartHome page
J C Hancox, K C R Patel, and J V Jones
Antiarrhythmics---from cell to clinic: past, present, and future
Heart, July 1, 2000; 84(1): 14 - 24.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P Brugada, R Brugada, and J Brugada
Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V1to V3and sudden death
Eur. Heart J., February 2, 2000; 21(4): 321 - 326.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
D. M Roden and J. R Balser
A plethora of mechanisms in the HERG-related long QT syndrome: Genetics meets electrophysiology
Cardiovasc Res, November 1, 1999; 44(2): 242 - 246.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Abriel, C. Cabo, X. H. T. Wehrens, I. Rivolta, H. K. Motoike, M. Memmi, C. Napolitano, S. G. Priori, and R. S. Kass
Novel Arrhythmogenic Mechanism Revealed by a Long-QT Syndrome Mutation in the Cardiac Na+ Channel
Circ. Res., April 13, 2001; 88(7): 740 - 745.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Yang, H. Kanki, B. Drolet, T. Yang, J. Wei, P. C. Viswanathan, S. H. Hohnloser, W. Shimizu, P. J. Schwartz, M. Stanton, et al.
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Circulation, April 23, 2002; 105(16): 1943 - 1948.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (77)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Priori, S.G.
Right arrow Articles by Wilde, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priori, S.G.
Right arrow Articles by Wilde, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?